Literature DB >> 12235006

The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.

Christine A Iacobuzio-Donahue1, Pedram Argani, Paula M Hempen, Jessa Jones, Scott E Kern.   

Abstract

The gene expression patterns of desmoplasia are becoming exposed through the application of global gene expression technologies such as cDNA microarrays or serial analysis of gene expression (SAGE). These patterns represent the sum of the many cellular components of the host stromal response to an infiltrating carcinoma. In studies of human neoplasms, it would be useful to identify those prototypical genes that characteristically indicate the recognizable forms of the responses to individual tumor types. Such genes may offer clues to better understand the process of invasion itself, the interactions between tumor and host cells, and tumor-specific differences in invasion. We used SAGE-defined genes and in situ transcript labeling to characterize the desmoplastic stroma induced by infiltrating ductal carcinomas of the breast. Principal component analysis identified 103 SAGE tags as specific for invasive breast carcinomas, in comparison with in situ duct carcinomas or normal breast epithelium. Of these, 68 tags corresponded to known genes. Six of the 68 genes from this breast cancer "invasion-specific" cluster were further characterized by in situ hybridization to breast cancer tissues. Results of in situ hybridization demonstrated that each gene was expressed within one of five distinct regions of the invasive tumors (neoplastic epithelium; angioendothelium; inflammatory, panstromal, and juxtatumoral stroma), reflecting a defined architectural structure to the transcriptome of invasive breast cancers. Two of these 6 genes were specifically expressed by the stromal cells within the invasive carcinoma; however, 1 (collagen 1alpha1) was expressed throughout the stromal response (panstromal expression), whereas the second (osteonectin) was specifically expressed within the juxtatumoral stromal cells, indicating a critical "regionality" of gene expression within the stromal response itself. A comparison of the gene expression profiles of the juxtatumoral stroma in breast and pancreatic carcinomas indicated important differences between the two, suggesting tumor-specific or organ-specific differences in the desmoplastic responses. Some of the genes presented are novel markers of the invasive process, imply communication at the host/tumor interface, and suggest potential therapeutic targets.

Entities:  

Mesh:

Year:  2002        PMID: 12235006

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

2.  Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer.

Authors:  Stephanie Thomas; Peter Waterman; Suelin Chen; Brett Marinelli; Marc Seaman; Scott Rodig; Robert W Ross; Lee Josephson; Ralph Weissleder; Kimberly A Kelly
Journal:  J Nanomed Nanotechnol       Date:  2011-08

3.  Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro.

Authors:  Jennifer M Halbleib; Annika M Sääf; Patrick O Brown; W James Nelson
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

4.  The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer.

Authors:  Yan Xu; Huizi Duanmu; Zhiqiang Chang; Shanzhen Zhang; Zhenqi Li; Zihui Li; Yufeng Liu; Kening Li; Fujun Qiu; Xia Li
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

5.  Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Authors:  Hamideh Shahheydari; Sarah Frost; Brian J Smith; Guy E Groblewski; Yuyan Chen; Jennifer A Byrne
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

Review 6.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

7.  Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.

Authors:  Zhican Qu; Sabrina Van Ginkel; Anshu M Roy; Louise Westbrook; Mubina Nasrin; Yulia Maxuitenko; Andra R Frost; Delicia Carey; Wenquan Wang; Rongbao Li; William E Grizzle; Jaideep V Thottassery; Francis G Kern
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  Clusterin as a biomarker in murine and human intestinal neoplasia.

Authors:  Xiaodi Chen; Richard B Halberg; William M Ehrhardt; Jose Torrealba; William F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

9.  Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

Authors:  M Bauer; G Su; C Casper; R He; W Rehrauer; A Friedl
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.